David Ricks, CEO of Eli Lilly and Co (NYSE:LLY), expressed confidence in meeting the lofty revenue expectations set by Bank of America for the company’s upcoming drug launches.
What Happened: During an interview on CNBC’s Last Call on Monday, Ricks described the potential market for these drugs after Bank of America analysts projected $60 billion in revenue from these drugs by 2030 in March.
"I think it's possible," he said.
"It is in some ways kind of the mega market for health.”
Ricks highlighted that the company is trying to prove the efficacy of its drugs for not only weight loss but also obesity-driven diseases such as heart ...